Filing Details
- Accession Number:
- 0001181431-11-050371
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-09-23 17:33:42
- Reporting Period:
- 2011-09-21
- Filing Date:
- 2011-09-23
- Accepted Time:
- 2011-09-23 17:33:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1230355 | Trans1 Inc | TSON | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1241073 | Delphi Bioinvestments Vi Lp | 3000 Sand Hill Road, #1-135 Menlo Park CA 94025 | No | No | Yes | No | |
1270723 | Delphi Ventures Vi Lp | 3000 Sand Hill Rd, #1-135 Menlo Park CA 94025 | No | No | Yes | No | |
1270729 | Delphi Management Partners Vi Llc | 3000 Sand Hill Rd, #1-135 Menlo Park CA 94025 | No | No | Yes | No | |
1436285 | Delphi Ventures Viii Lp | 3000 Sand Hill Road, #1-135 Menlo Park CA 94025 | No | No | Yes | No | |
1451526 | Delphi Bioinvestments Viii Lp | 3000 Sand Hill Road, #1-135 Menlo Park CA 94025 | No | No | Yes | No | |
1457494 | Delphi Management Partners Viii, L.l.c. | 3000 Sand Hill Road, #1-135 Menlo Park CA 94025 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-09-21 | 1,523,584 | $3.25 | 2,410,523 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2011-09-21 | 14,877 | $3.25 | 23,538 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,236,272 | Indirect | See footnote |
Common Stock | 22,362 | Indirect | See footnote |
Footnotes
- The reported securities are owned directly by Delphi Ventures VIII, L.P. ("Delphi VIII"). Delphi Management Partners VIII, L.L.C. ("DMP VIII") is the general partner of Delphi VIII and Delphi BioInvestments VIII, L.P. ("DBI VIII" and together with Delphi VIII, the "Delphi VIII Funds") and may be deemed to have sole voting and dispositive power over the shares held by the Delphi VIII Funds. DMP VIII and each of James J. Bochnowski, David L. Douglass, Douglas A. Roeder, John F. Maroney and Deepika R. Pakianathan, Ph.D., the Managing Members of DMP VIII who may be deemed to share voting and dispositive power over the reported securities, disclaim beneficial ownership of the reported securities held by the Delphi VIII Funds except to the extent of any pecuniary interest therein.
- The reported securities are owned directly by DBI VIII. DMP VIII is the general partner of Delphi VIII and DBI VIII and may be deemed to have sole voting and dispositive power over the shares held by the Delphi VIII Funds. DMP VIII and each of James J. Bochnowski, David L. Douglass, Douglas A. Roeder, John F. Maroney and Deepika R. Pakianathan, Ph.D., the Managing Members of DMP VIII who may be deemed to share voting and dispositive power over the reported securities, disclaim beneficial ownership of the reported securities held by the Delphi VIII Funds except to the extent of any pecuniary interest therein.
- The reported securities are owned directly by Delphi Ventures VI, L.P. ("Delphi VI"). Delphi Management Partners VI, L.L.C. ("DMP VI") is the general partner of Delphi VI and Delphi BioInvestments VI, L.P. ("DBI VI" and together with Delphi VI, the "Delphi VI Funds") and may be deemed to have sole voting and dispositive power over the shares held by the Delphi VI Funds. DMP VI and each of James J. Bochnowski, David L. Douglass, Douglas A. Roeder, John F. Maroney and Deepika R. Pakianathan, Ph.D., the Managing Members of DMP VI who may be deemed to share voting and dispositive power over the reported securities, disclaim beneficial ownership of the reported securities held by the Delphi VI Funds except to the extent of any pecuniary interest therein.
- The reported securities are owned directly by DBI VI. DMP VI is the general partner of Delphi VI and DBI VI and may be deemed to have sole voting and dispositive power over the shares held by the Delphi VI Funds. DMP VI and each of James J. Bochnowski, David L. Douglass, Douglas A. Roeder, John F. Maroney and Deepika R. Pakianathan, Ph.D., the Managing Members of DMP VI who may be deemed to share voting and dispositive power over the reported securities, disclaim beneficial ownership of the reported securities held by the Delphi VI Funds except to the extent of any pecuniary interest therein.